News Focus
News Focus
Followers 74
Posts 15870
Boards Moderated 0
Alias Born 04/26/2010

Re: louieblouie post# 332636

Sunday, 04/04/2021 12:34:49 PM

Sunday, April 04, 2021 12:34:49 PM

Post# of 448123

Mr. Kasanoff’s motion is the result of an online crowdfunding campaign by disgruntled retail investors in Amarin stock. For the past year, Mr. Kasanoff and other retail investors have concocted various conspiracy theories on online message boards regarding this Court’s
judgment.



Who cares how the legal work was funded? That's just an attempt to belittle us "disgruntled shareholders" - like we should be happy Du stole millions of dollars of personal wealth from us, and billions in MC from AMRN? Not surprised that they've been following the MB for over a year. They claimed multiple times that the EPADI II has no standing to file the Rule 24 and 60 docs - how does marjac rebut this part? (ignore the lack of standing part, focus on "claim or defense" part)

EPADI II
next asks to intervene permissively under Rule 24(b)(1)(B). Mot. 10–12. But that rule requires “a
claim or defense that shares with the main action a common question of law or fact,” and EPADI II
does not articulate any “claim or defense
,” let alone one that shares a common question of law or fact
with the patent infringement claims in this case. Fed. R. Civ. P. 24(b)(1)(B). Indeed, EPADI II has
not even filed a pleading, as required by Rule 24(c).
EPADI II admits it is “not . . . raising new causes
of action” and instead “stand[s] on Amarin’s pleadings already on file.” Mot. 12–13. Yet Amarin’s
pleadings only state claims for patent infringement, and again, EPADI II does not own, license, or
claim any other right to the patents-in-suit. Mot. 6. EPADI II’s failure to plead any claim or defense,
and its lack of standing to pursue the patent claims under which this case arose, are fatal.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News